HERCOLES GROUP

Hepatocarcinoma Recurrence on the Liver Study Group

[Jordi Gracia-Sancho @JSGracia]

What’s the pathophysiology of hepatic ischemia and reperfusion injury?

So fortunate to coordinate this international collaborative work with colleagues and friends‼️

Special congrats to first author @EricFelli❕

Now in @LTxJournal: https://t.co/tX8WDBS6vZ

RT if you like it 😊

[ISGPS @ISGPS_news]

Claudio Bassi, founding father of the ISGPS, husband, father, surgeon, professors, musician and much more passed away last night. Words fall short of expressing our sorrow. ❤️

[Japanese Society of HBP Surgery @JSHBPS]

⚔️New resectability criteria for pancreatic cancer⚔️
👩‍👩‍👧‍👧Experts from West and East👩‍👩‍👧‍👧

🅰️ Anatomy 🫁
🅱️ Biology 🎆
©️ Condition 👨‍🦽

👉"ABC" parameters are equally important.

🤜Collaboration is necessary 🤛
@IHPBA @AHPBA @EAHPBA

https://t.co/o7Lvlqq6Ej

[Julio Mayol @juliomayol]

Ongoing research and guidelines: As AI technology continues to evolve, ongoing research and development of guidelines are necessary to address the challenges posed by AI-generated content in scientific manuscripts.

[E-AHPBA @EAHPBA]

Looking forward to meeting you all in Lyon!!! 😉

Countdown is on… ⏰

[GUIDO TORZILLI @TorzilliGuido]

ESSU (European School of Surgical Ultrasound) is back! On May 17-19th & July 5-7th we will host the first two 2023 Courses
Registrations are open at https://t.co/Edbw3bJuNu

@IHPBA @EAHPBA @APHPBA2023 @AHPBA @SSATNews @IASGO_1988 @SIC_chirurgia

[Simone Famularo @simonefamularo]

Will you Participate to the next @DDWMeeting 2023? It will be an opportunity to discuss about prognosis prediction in #surgicaloncology by 🤖 #AI and #ML models! @EAHPBA @IHPBA @Laparoscopes @hpb_so @HPB_influencer @surgery_ai

[Simone Famularo @simonefamularo]

Tried #segmentanything from @MetaAI for tumor detection at CT: this is the result after 1 click. It seems highly accurate! Now testing it to automatize radiomics features extraction! What do you think?@IHPBA @EAHPBA @Laparoscopes @p_masca @surgery_ai @ewenharrison @HPB_influencer

[Simone Famularo @simonefamularo]

new Italian HCC guidelines: thanks also to the @HercolesGroup recent paper on @AnnalsofSurgery (https://t.co/JEScbsstUT), finally 🪡LIVER RESECTION is the 1⃣ line treatment for BCLC-C!⏰Time to change @EASLnews 's guidelines?! https://t.co/I4NjRUQB0G @IHPBA @EAHPBA @AisfFegato

[Simone Famularo @simonefamularo]

Should we really stop ourselves in case of PD after #neoadjCHT for #CRLM? Should we really consider it an unfavourable sign? When resectable, even with high tumor burden, we drastically increase OS compared to CHT prosecution! https://t.co/xWBRuqS9DG @IHPBA @EAHPBA @timpawlik

[Simone Famularo @simonefamularo]

How to select patients to submit to neoadj cht or to upfront liver resection for CRLM? Check out our new machine-learning algorithm to establish the best potential oncologic treatment!High tumor burden without R1vasc=Upfront!https://t.co/nwMVp92ukW @TorzilliGuido @IHPBA @EAHPBA

[Simone Famularo @simonefamularo]

HE.RC.O.LE.S. Tv 📺is now online! 🎯Published the first 6 videos from the last cycle of international webinars, 6 pills freely available about HCC staging, lap and rob surgery, preop assessment and ERAS https://t.co/2jo2LzxRcY @IHPBA @rubenciria @ma5RN @HPB_influencer @EAHPBA

[HERCOLES GROUP @HercolesGroup]

@simonefamularo @JAMASurgery @hpb_so @IHPBA @HPB_influencer @EAHPBA #AI and machine learning could really change the surgical experience!But large multicentric #data are mandatory, as in this 🇮🇹🇯🇵 study. what do you think?

[Simone Famularo @simonefamularo]

📢check the last @HercolesGroup paper on @JAMASurgery!How to decide the treatment for recurrent HCC? Our #machinelearning 🤖 prediction model will allow the best evaluation during your #multidisciplinary board ! @hpb_so @IHPBA @HPB_influencer @EAHPBA
https://t.co/VCoPK5OYzK

[HERCOLES GROUP @HercolesGroup]

@labnol ❤️ #TwitterBots

[The Lancet Haematology @TheLancetHaem]

NEW: In a ph 3 RCT, addition of isatuximab to lenalidomide, bortezomib, and dexamethasone induction therapy for transplantation-eligible NDMM improved MRD negativity by FC (166 [50%] of 331 vs 117 [36%] of 329; OR 1·82, 95% CI 1·33–2·48; p=0·00017). #mmsm
https://t.co/ztHrtag57Z

[Marc Besselink @MarcBesselink]

@EAHPBA 2019 Amsterdam: 950 attendees, 58 countries! Thanks to Olivier Busch and team. Looking forward to 2021 Bilbao & 2023 Lyon. Improving outcomes for our HPB patients. #EAHPBA2019

[Annals of Surgery @AnnalsofSurgery]

A Japanese study has reported that surgery for recurrent hepatocellular carcinoma may improve long-term survival from not only intrahepatic recurrence but also for extrahepatic recurrence in selected patients.

https://t.co/GMOYMwaduI

[SIDP @SIDPharm]

Recent article in @JAMASurgery found that increasing durations of antibiotic prophylaxis was associated with higher odds of AKI and C difficile infection. Authors noted that "EVERY DAY MATTERS". NNH for AKI after receiving at least 72h of prophylaxis = 4. https://t.co/Q6SEcHzDnj

[SIC @SIC_chirurgia]

E' pronto il Piano per lo sviluppo in Italia della tecnologia Car-T per il trattamento dei #tumori. Il progetto è stato inviato alla commissione Cultura della Camera, che dovrà esaminarlo prima che si renda operativo
#ricerca #CarT
https://t.co/lHEOxs49z8